Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Biotechpharma UAB. (10/1/18). "Press Release: Biotechpharma UAB Appoints Frank Ternes as Chief Business Officer".

Organisations Organisation Biotechpharma UAB
  Group Northway (Group)
  Organisation 2 Rentschler Biotechnologie GmbH
  Today Rentschler Biopharma SE
  Group Rentschler (Group)
Products Product contract manufacturing (biologicals)
  Product 2 biopharmaceutical
Persons Person Ternes, Frank (Northway 201810– CBO at Biotechpharma UAB before Rentschler + Boehringer Ingelheim)
  Person 2 Bumelis, Vladas Algirdas (Northway 201812– Board Chairman of Biotechpharma UAB before CEO + Founder of Biotechpharma)

Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, is pleased to announce the appointment of Frank Ternes as Chief Business Officer effective from 1 October 2018. Frank will manage all sales, marketing and business development functions and will report directly to CEO, Dr. Vladas Algirdas Bumelis.

Frank is a passionate leader who has a vast amount of experience within the life sciences industry. During his 30-year career, he has held a variety of senior roles, most recently including Chief Business Officer of Rentschler Biotechnologie and Sr VP Contract Manufacturing Business of Boehringer Ingelheim.

Dr Bumelis, CEO of Biotechpharma said:

“I am delighted that Frank will be joining our team at this exciting time for the company, and I look forward to working with him as we strive to ensure continuous growth of the company, expand our footprint in the US market and improve the experience of our customers. Frank brings with him a wealth of experience spanning operations, sales, business development and management and he will help to achieve ambitious goal of Biotechpharma to become a Top 10 player in large molecule CDMO industry.”

Frank Ternes commented:

“I am looking forward to be joining Biotechpharma, a fast growing player in biologics CDMO market that has an exciting vision and international growth strategy. It is an exciting proposition to work with the team to grow Biotechpharma’s customers base worldwide and drive the implementation of its business expansion plan.”

Record changed: 2019-05-01


Picture [iito] Plain Stupid Simple 650x80px

More documents for Northway (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top